GB0009223206
© Globe Newswire
27.10.2025
SN
LISTED
LSE
Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices in orthopedic and cardiovascular surgery....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
SN
LISTED
LSE
UFC® and Smith+Nephew announce multi-year extension of partnership
News Preview
Smith+Nephew to continue as UFC’s Preferred Sports Medicine Technology Partner...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2025
SN
LISTED
LSE
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT) code for procedures involving its CARTIHEAL AGILI-C Cartilage Repair Implant, effective January 1, 2027. ...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
03.10.2025
SN
LISTED
LSE
Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention
News Preview
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound Journal,1 demonstrating the pressure injury prevention mechanism of action of ALLEVYN COMPLETE CARE Foam Dressing and its ability to absorb and dissip...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
01.10.2025
SN
LISTED
LSE
Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty
News Preview
Completes the CORIOGRAPH Services portfolio which also includes solutions for knee and hip arthroplasty...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2025
SN
LISTED
LSE
Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant and support its further adoption. Substantial investment into research to expand access and indications have led to these important results designed to...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
SN
LISTED
LSE
Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the CENTRIO Platelet-Rich-Plasma (PRP) System, a biodynamic hematogel derived from a patient’s own platelets and plasma that, once applied, may assist the natural healing process by maintaining a moist wound environment. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.07.2025
SN
LISTED
LSE
Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint spaces including Shoulder, Hip, and Foot & Ankle. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.06.2025
SN
LISTED
LSE
Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select players during high profile matches at The Championships, Wimbledon in 2025. The world’s oldest and most prestigious tennis tournament serves as a perfect backdrop to showcase Smith+Nephew’s purpose of ‘Life Unlimited’ - making a diff...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.06.2025
SN
LISTED
LSE
Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures
News Preview
The future of fracture fixation with novel side-specific nails featuring variable angle locking technology...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.06.2025
SN
LISTED
LSE
Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.06.2025
SN
LISTED
LSE
Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading joint...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
09.06.2025
SN
LISTED
LSE
New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.1...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.05.2025
SN
LISTED
LSE
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of Defense (DoD) through the Defense Logistics Agency (DLA)....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.05.2025
SN
LISTED
LSE
Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*
News Preview
The CARTIHEAL Implant will be featured at the Arthroscopy Association of North America Annual Meeting (AANA 2025) this week...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
SN
LISTED
LSE
Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland
News Preview
“CORI on Tour” will highlight the latest advancements in robotics-assisted surgery for hip and knee joint replacement...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
SN
LISTED
LSE
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic Reconstruction at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego this week. Some of the highlighted technologies will include:...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.03.2025
SN
LISTED
LSE
Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego this week. Some of the highlighted technologies will include:...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.03.2025
SN
LISTED
LSE
New report confirms Smith+Nephew’s OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) highlights the exceptional performance of Smith+Nephew’s proprietary OXINIUM on highly cross-linked polyethylene. The data indicates th...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.02.2025
SN
LISTED
LSE
Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand
News Preview
First in market to offer Adjustable Tensioning Technology* for insertional Achilles reconstruction and lateral ankle instability repair...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.02.2025
SN
LISTED
LSE
Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes
News Preview
Healthcare professionals are invited to register for the livestream option as a courtesy here...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.01.2025
SN
LISTED
LSE
Smith+Nephew’s ALLEVYN™ LIFE Sacrum Foam Dressing and LEAF™ Patient Monitoring System receive ‘favorable’ Evidence Bar™ ratings from ECRI for pressure injury prevention
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI – leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence Assessments of ALLEVYN LIFE Sacrum Foam Dressings and the LEAF Patient Monitoring System. In their latest reports, ECRI upgraded its Evidence Bar ratin...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.12.2024
SN
LISTED
LSE
Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty
News Preview
Latest expansion to the CORI◊ Surgical System portfolio provides a personalized solution for patients and surgeons...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.12.2024
SN
LISTED
LSE
Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless anatomic total shoulder for the AETOS Shoulder System (AETOS Stemless). ...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2024
SN
LISTED
LSE
RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design
News Preview
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recognizing its intuitive pairing of NPWT housed in a patient-friendly design....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.10.2024
SN
LISTED
LSE
Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery
News Preview
Patented technology further personalizes total knee arthroplasty for surgeons and patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.09.2024
SN
LISTED
LSE
First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System. Designed to address the evolving demands of primary hip surgery - including the increased adoption of anterior approach procedures – the CATALYSTEM Primary...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2024
SN
LISTED
LSE
Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its TOTAL ANKLE Patient-Matched Guides, giving surgeons a predictable and efficient option to help plan and perform total ankle replacement (TAR) procedures. Engineered using 3D Systems’ VSP® surgical planning workflows, all-in-one TOTAL ANKLE Pati...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.06.2024
SN
LISTED
LSE
Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavours to help people live their ‘Life Unlimited’ by aidi...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
